Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults

Br J Haematol. 2019 Jul;186(1):130-133. doi: 10.1111/bjh.15698. Epub 2018 Dec 5.

Authors

Sylvie D Freeman¹, Robert K Hills², Nigel H Russell³; UK NCRI AML Trial Group; Jacqueline Cloos⁴, Angèle Kelder⁴, Gert J Ossenkoppele⁴, Gerrit J Schuurhuis⁴; HOVON AML Trial Group

Affiliations

¹ Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
² Centre for Trials Research Cardiff University, Cardiff, UK.
³ Nottingham University Hospital, Nottingham, UK.
⁴ Amsterdam UMC, Location VUMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.

PMID: 30520018
DOI: 10.1111/bjh.15698

No abstract available

Keywords: acute leukaemia; flow cytometry; measurable residual disease.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Female
Flow Cytometry / methods*
Humans
Induction Chemotherapy
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / drug therapy*
Male
Neoplasm, Residual / diagnosis*

Grants and funding